From:  Transurethral laser ablation using 980-nm diode laser for recurrent non-muscle invasive bladder cancer

 Comparison of perioperative outcomes between TULA and TURBT.

Perioperative outcomesTULA (n = 24)TURBT (n = 24)p-value *
Operating time (min)39.04 ± 19.03
(13–91)
60.21 ± 39.79
(17–199)
p < 0.05
Bladder irrigation (day)0.33 ± 0.76
(0–2)
1.92 ± 0.28
(1–2)
p < 0.05
Catheterization (day)1.17 ± 1.00
(0–2)
2.17 ± 0.76
(0–4)
p < 0.05
Hospital stay (day)5.96 ± 1.81
(4–13)
7.46 ± 1.47
(5–11)
p < 0.05
Hospital stay after operation (day)2.13 ± 1.70
(1–9)
3.83 ± 1.34
(2–6)
p < 0.05

*: t-test.